US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Hydrogen Peroxide Topical Solution USP

Reason Cross Contamination With Other Products: Product is cross contaminated with low levels of isopropyl alcohol.

Vi-Jon, LLC NDC 21130-871-43 D-1244-2022
Class II · Moderate risk Terminated

Launch Sequence Aphrodisia Capsules

Reason Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.

Loud Muscle Science D-1341-2022
Class II · Moderate risk Terminated

Launch Sequence Euphoria Capsules

Reason Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.

Loud Muscle Science D-1340-2022
Class II · Moderate risk Terminated

Launch Sequence Capsules

Reason Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.

Loud Muscle Science D-1339-2022
Class II · Moderate risk Terminated

Divalproex Sodium Delayed-Release Tablets

Reason Failed Dissolution Specifications: Failure occurred during routine stability testing of dissolution test.

Sun Pharmaceutical Industries INC NDC 62756-798-88 D-1291-2022
Class II · Moderate risk Terminated

Hydrogen Peroxide Topical Solution

Reason Labeling: Label Mix-Up-The primary label on the front of the bottles have Hydrogen Peroxide affixed to the front and back of the containers. However, the product inside the bottle is 70% Isopropyl Alcohol.

Vi-Jon, LLC NDC 59779-871-45 D-1191-2022
Class II · Moderate risk Terminated

Testosterone Cypionate Injection

Reason cGMP - Water leakage

Sun Pharmaceutical Industries INC NDC 62756-015-40 D-1190-2022
Class II · Moderate risk Terminated

Draximage MAA

Reason Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing.

Jubilant Draximage Inc NDC 65174-270-30 D-1189-2022
Class II · Moderate risk Terminated

Eszopiclone Tablets

Reason Shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles.

Macleods Pharma Usa Inc NDC 33342-299-07 D-1174-2022
Class II · Moderate risk Terminated

70% ISOPROPYL ALCOHOL First aid antiseptic

Reason Defective Container: Product may leak when squeezed or when not in an upright position determined to be due to defects in the bottle neck finish and insufficient tightening.

Vi-Jon, LLC D-1151-2022
Class II · Moderate risk Terminated

Tretinoin Capsules

Reason Failed Dissolution Specifications; Low Out of Specification (OOS) results for dissolution.

Teva Pharmaceuticals USA Inc NDC 0555-0808-02 D-1156-2022
Class II · Moderate risk Terminated

Fluticasone Propionate Nasal Spray

Reason Defective container: defect prevents product from dispensing as intended.

Akorn, Inc. NDC 50383-700-16 D-1172-2022
Class II · Moderate risk Terminated

Estriol 1mg/gm

Reason Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

Wedgewood Village Pharmacy, LLC D-1186-2022
Class II · Moderate risk Terminated

Estriol 1mg/gm

Reason Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

Wedgewood Village Pharmacy, LLC D-1185-2022
Class II · Moderate risk Terminated

Boric Acid 600 mg per suppository

Reason Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

Wedgewood Village Pharmacy, LLC D-1184-2022
Class II · Moderate risk Terminated

Boric Acid 600 mg capsules

Reason Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

Wedgewood Village Pharmacy, LLC D-1183-2022
Class II · Moderate risk Terminated

Doxycycline

Reason Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

Wedgewood Village Pharmacy, LLC D-1182-2022
Class II · Moderate risk Terminated

Bethanechol Chloride 1mg/ml

Reason Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

Wedgewood Village Pharmacy, LLC D-1181-2022
Class II · Moderate risk Terminated

Calcipotriene Topical Solution

Reason Defective Delivery System: Potential defect that could prevent the product from dispensing as intended.

Akorn, Inc. D-1170-2022
Class II · Moderate risk Terminated

Testosterone Cypionate Injection

Reason Lack of Assurance of Sterility: Manufacturing deviation which was reported due to a microbial excursion

Sun Pharmaceutical Industries INC NDC 62756-015-40 D-1154-2022
Class II · Moderate risk Terminated

Zileuton Extended-Release Tablets

Reason Failed Dissolution Specifications: Out of specification test results observed in dissolution testing during long term stability study.

Lupin Pharmaceuticals Inc. NDC 68180-169-16 D-1150-2022
Class II · Moderate risk Terminated

Clonidine Transdermal System

Reason Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.

Mayne Pharma Inc NDC 51862-455-01 D-1152-2022
Class II · Moderate risk Terminated

CORRECTDOSE Children's COUGH & CHEST CONGESTION DM

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 62320-321-05 D-1494-2022
Class II · Moderate risk Terminated

CORRECTDOSE Children's PAIN RELIEF & Fever Reducer

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 62320-311-05 D-1493-2022